فاس نيوز ميديا جريدة الكترونية جهوية تعنى بشؤون و أخبار جهة فاس مكناس – متجددة على مدار الساعة
In a move aimed at enhancing oversight and regulation within Morocco’s pharmaceutical sector, the government, during its weekly meeting on Thursday, October 24, 2024, approved two draft decrees as part of the continued implementation of Law No. 17.04, concerning the Pharmacy and Medicine Code. These decrees focus on updating the mechanisms for pharmaceutical advertising and reinforcing good manufacturing practices.
Mustapha Baitas, Minister Delegate to the Head of Government in charge of Relations with Parliament and government spokesperson, explained in a press conference following the meeting that the first decree, No. 2.24.346, pertains to the application of Articles 42 and 44 of the Medicine and Pharmacy Code.
He elaborated that this decree aims to regulate the procedure for submitting requests for advertising approval for medicines intended for human use, setting clear rules for advertising disclosures to healthcare professionals.
The second decree, No. 2.24.327, addresses the Free Sale Certificate and the Certificate of Compliance with Good Manufacturing Practices.
According to Baitas, this decree organizes the process for submitting requests for these certificates, specifying deadlines for their issuance and validity, thereby bolstering confidence in the quality of locally manufactured and exported medicines.
Amin Tahraoui, Minister of Health and Social Protection, emphasized that these decrees mark a crucial step toward better regulation of Morocco’s pharmaceutical market.
He noted that these legal reforms come in preparation for the implementation of Law No. 10.22, which will establish the Moroccan Agency for Medicines and Health Products, a new entity tasked with comprehensive oversight and regulation of the sector.
In conclusion, the implementation of these decrees is expected to increase transparency and oversight in Morocco’s pharmaceutical market, fostering greater trust among citizens and professionals in the quality of available medicines and ensuring compliance with the highest standards of pharmaceutical manufacturing.
Source: fesnews media
